Vieira A L, Vale A, Melo N, Caetano Mota P, Jesus J M, Cunha R, Guimarães S, Souto Moura C, Morais A
Pulmonology Department, Hospital de Braga, Braga, Portugal.
Pulmonology Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):129-138. doi: 10.36141/svdld.v35i2.6860. Epub 2018 Apr 28.
: Organizing pneumonia (OP) is classified as an acute/subacute pneumonia according to the American Thoracic Society/European Respiratory Society statement (2013 update). Although its clinical presentation, radiologic and histologic features are well established, data on the relevance of potential causes, corticosteroid doses and length, or management of relapses are based on heterogeneous series of patients. : The aims of this study were to describe clinical presentation, diagnosis and treatment of OP, explore potential causes, discuss strategies for managing relapses, and analyze prognostic factors. We also discuss our findings in relation to relevant data in the literature. : We performed a cross-sectional study of all patients diagnosed with OP at a tertiary referral center in northern Portugal between 2008 and 2015. : Sixty-seven patients were diagnosed with OP over the 7-year study period. Dyspnea and cough were the most common presenting symptoms and approximately 30% of patients were hospitalized at the time of diagnosis. Approximately half of the patients were receiving drugs described as potential causes of OP. Microorganisms were isolated in approximately one-third of patients. Other potential causes identified were hematologic disorders, neoplasms, connective tissue diseases, myelodysplastic syndromes, immunodeficiencies, radiotherapy, and bird exposure. Cryptogenic OP was diagnosed in just 16 patients (23.8%). Corticosteroids were the most common treatment and 11 patients (16.4%) experienced relapse. : The findings for this series of patients confirm the extreme variability of the contexts in which OP can occur and suggest that rather than a distinct, homogeneous clinicopathologic entity, OP is a non-specific reaction whose outcomes are dependent on the cause. .
根据美国胸科学会/欧洲呼吸学会声明(2013年更新),机化性肺炎(OP)被归类为急性/亚急性肺炎。尽管其临床表现、放射学和组织学特征已明确,但关于潜在病因的相关性、皮质类固醇剂量和疗程或复发管理的数据基于不同的患者系列。
本研究的目的是描述OP的临床表现、诊断和治疗,探索潜在病因,讨论复发管理策略,并分析预后因素。我们还将结合文献中的相关数据讨论我们的研究结果。
我们对2008年至2015年期间在葡萄牙北部一家三级转诊中心诊断为OP的所有患者进行了横断面研究。
在7年的研究期间,67例患者被诊断为OP。呼吸困难和咳嗽是最常见的首发症状,约30%的患者在诊断时住院。约一半的患者正在服用被描述为OP潜在病因的药物。约三分之一的患者分离出微生物。确定的其他潜在病因包括血液系统疾病、肿瘤、结缔组织病、骨髓增生异常综合征、免疫缺陷、放疗和接触鸟类。仅16例患者(23.8%)被诊断为隐源性OP。皮质类固醇是最常见的治疗方法,11例患者(16.4%)复发。
这一系列患者的研究结果证实了OP发生背景的极端变异性,并表明OP不是一个独特的、同质的临床病理实体,而是一种非特异性反应,其结果取决于病因。